肺炎支原体肺炎与预后相关的临床指标

doi:10.12372/jcp.2022.22e0170

Abstract

Abstract:

Mycoplasma pneumoniae (MP) results in community-acquired pneumonia in children by causing direct damage and immune damage to respiratory tissue. At present, refractory Mycoplasma pneumoniae pneumonia (RMPP), MPP complications such as bronchial mucous plugs, bronchiolitis obliterans, etc., have increased significantly. Therefore, it is very important to grasp the clinical indicators for the prediction and diagnosis of RMPP and MPP-related complications for the prognosis of childhood diseases.

Key words: Mycoplasma pneumoniae pneumonia, prediction, clinical indicator, child

LIU Feng. Clinical indicators related to prognosis of Mycoplasma pneumoniae pneumonia[J].Journal of Clinical Pediatrics, 2022, 40(4): 247-251.

References 30

[1]	Ding Y, Chu C, Li Y, et al. High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia[J]. BMC Infect Dis, 2018, 18:439. doi: 10.1186/s12879-018-3346-8
[2]	Meyer Sauteur PM, van Rossum AM, Vink C. Mycoplasma pneumoniae in children: carriage, pathogenesis, and antibiotic resistance[J]. Curr Opin Infect Dis, 2014, 27(3):220-227. doi: 10.1097/QCO.0000000000000063
[3]	Jiang ZL, Li SH, Zhu CM, et al, Mycoplasma pneumoniae infections: pathogenesis and vaccine development[J]. Pathogens, 2021, 10(2):119. doi: 10.3390/pathogens10020119
[4]	Tamura A, Matsubara K, Tanaka T, et al. Methyl-prednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children[J]. J Infect, 2008, 57(3):223-228.
[5]	卢志威, 赵辉, 郑跃杰, 等. 三种方法对儿童肺炎支原体感染诊断的动态评价[J]. 临床儿科杂志, 2012, 30(4):382-385.
[6]	Zhu Y, Wang J. Logistic regression analysis of high risk factors of mycoplasma pneumoniae pneumonia in children[J]. Hebei Med, 2018, 24:60-63.
[7]	Qu BN, Chi L, Zhu ZW, et al. Clinical characteristics and high risk factors of mycoplasma pneumoniae pneumonia in children[J]. Chin Pediatr Integrated Traditi Western Med, 2019, 11:58-62.
[8]	Liu XM, Cui ZZ, Yang G, et al. Analysis of risk factors of Mycoplasma pneumoniae pneumonia[J]. China J Modern Med, 2019, 10:1-8.
[9]	Gong Hui, Sun Baijun, Chen Ye, et al. The risk factors of children acquiring refractory mycoplasma pneumoniae pneumonia: a meta-analysis[J]. Medicine (Baltimore), 2021, 100:e24894. doi: 10.1097/MD.0000000000024894
[10]	Liu XF, Zhao ZM, Zhang ZP, et al. Analysis of risk factors of Mycoplasma pneumoniae pneumonia in children[J]. Hebei Med, 2017, 23:780-783.
[11]	Zhou YA. Changes of C-reactive protein in the course of mycoplasma pneumonia and its clinical significance[J]. Chin J Misdiagnosis, 2011, 11:3567-3569.
[12]	Wen J, Su Y, Sun H, et al. The combination of initial markers to predict refractory Mycoplasma pneumoniae pneumonia in Chinese children: a case control study[J]. Respir Res, 2021, 22(1):89. doi: 10.1186/s12931-020-01577-9
[13]	Yuan SJ, Xie HT, Li ZL. Clinical significance of hypersensitive C-reactive protein, fribrinogen and D-dimmer in connective tissue disease-related interstitial lung disease[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2017, 37:415-419.
[14]	Kazama I, Nakajima T. Acute bronchitis caused by bordetella pertussis possibly co-infected with Mycoplasma Pneumoniae[J]. Am J Case Rep, 2019, 20:60-64. doi: 10.12659/AJCR.913430
[15]	Tezol O, Bozlu G, Sagcan F, et al. Value of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio and red blood cell distribution width in distinguishing between reactive lymphadenopathy and lymphoma in children[J]. Bratisl Lek Listy, 2020, 121:287-292.
[16]	Balta S, Demirkol S, Kucuk U. The platelet lymphocyte ratio may be useful inflammatory indicator in clinical practice[J]. Hemodial Int, 2013, 17:668-669.
[17]	Patel N, Penkert RR, Jones BG, et al. Baseline serum vitamin A and D levels determine benefit of oral vitamin A&D supplements to humoral immune responses following pediatric influenza vaccination[J]. Viruses, 2019, 11(10):907. doi: 10.3390/v11100907
[18]	Ling Y, Ning J, Xu Y. Explore the predictive value of peripheral blood cell parameters in refractory mycoplasma pneumoniae pneumonia in children over 6 years old[J]. Front Pediatr, 2021, 9:659677. doi: 10.3389/fped.2021.659677
[19]	Huang X, Li D, Liu F, et al. Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia[J]. BMC Infectious Diseases, 2021, 21(1):14. doi: 10.1186/s12879-020-05700-5 pmid: 33407216
[20]	Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children[J]. N Engl J Med, 2015, 372(9):835-845. doi: 10.1056/NEJMoa1405870
[21]	Gao LW, Yin J, Hu YH, et al. The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016[J]. Epidemiol Infect, 2019, 147:e192. doi: 10.1017/S0950268819000839
[22]	Zhang Y, Zhou Y, Li S, et al. The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children[J]. PLoS One, 2016, 11(5):e0156465. doi: 10.1371/journal.pone.0156465
[23]	Bi Y, Zhu Y, Ma X, et al. Development of a scale for early prediction of refractory Mycoplasma pneumoniae pneumonia in hospitalized children[J]. Sci Rep, 2021, 11(1):6595. doi: 10.1038/s41598-021-86086-5
[24]	Zhao Q, Zhang T, Zhu B, et al. Increasing age affected polymorphonuclear neutrophils in prognosis of Myco-plasma pneumoniae pneumonia[J]. J Inflamm Res, 2021, 14:3933-3943. doi: 10.2147/JIR.S321656
[25]	Daxboeck F, Gattringer R, Mustafa S, et al. Elevated serum alanine aminotransferase (ALT) levels in patients with serologically verified Mycoplasma pneumoniae pneumonia[J]. Clin Microbiol Infect, 2010, 11(6):507-510. doi: 10.1111/j.1469-0691.2005.01154.x
[26]	Xu Q, Zhang L, Hao C, et al. Prediction of bronchial mucus plugs formation in patients with refractory Mycoplasma pneumoniae pneumonia[J]. J Trop Pediatr, 2017, 63(2):148-154.
[27]	Xu X, Li H, Sheng Y, et al. Nomogram for prediction of bronchial mucus plugs in children with Mycoplasma pneumoniae pneumonia[J]. Sci Rep, 2020, 10(1):4579. doi: 10.1038/s41598-020-61348-w
[28]	Smeijsters KMG, Bijkerk RM, Daniels JMA, et al. Effect of bronchoscopy on gas exchange and respiratory mechanics in critically ill patients with atelectasis: an observational cohort study[J]. Front Med, 2018, 5:301. doi: 10.3389/fmed.2018.00301
[29]	Kavaliunaite E, Aurora P. Diagnosing and managing bronchiolitis obliterans in children[J]. Expert Rev Respir Med, 2019, 13(5):481-488. doi: 10.1080/17476348.2019.1586537
[30]	Cheng Q, Zhang H, Shang Y, et al. Clinical features and risk factors analysis of bronchitis obliterans due to refractory Mycoplasma pneumoniae pneumonia in children: a nomogram prediction model[J]. BMC Infect Dis, 2021, 21(1):1085. doi: 10.1186/s12879-021-06783-4 pmid: 34674642

Metrics

Viewed

Full text

791

HTML			PDF

Just accepted	Online first	Issue	Just accepted	Online first	Issue
0	0	212	0	0	579

From	Others	local

Times	219	572
Rate	28%	72%

Abstract

635

Just accepted	Online first	Issue

0	0	635

From	Others	local

Times	29	606
Rate	5%	95%

Cited

Web of Science	Crossref	ScienceDirect	Search for Citations in Google Scholar >>


This page requires you have already subscribed to WoS.

Shared

Clinical indicators related to prognosis of Mycoplasma pneumoniae pneumonia

RichHTML

PDF (PC)

Like

Knowledge

Cited

Abstract

Cite this article

share this article

References 30

Related Articles 15

Metrics

Comments

Recommended 0

[1]	LUO Mingjing, YU Jiaming, WANG Xiaodong, ZHANG Xiaoling, YU Yue, ZHANG Yu, WEN Feiqiu, LIU Sixi. Clinical analysis of invasive fungal disease secondary to allogeneic hematopoietic stem cell transplantation in 424 children with thalassemia [J]. Journal of Clinical Pediatrics, 2025, 43(1): 21-28.
[2]	LIU Dongxia, JIN Rong, LIN Rongjun. Risk factors analysis of severe refractory Mycoplasma pneumoniae pneumonia complicated with bronchitis obliterans in children [J]. Journal of Clinical Pediatrics, 2025, 43(1): 29-34.
[3]	ZHONG Jinhong, WANG Can, CHEN Fang. Progress in the research of infantile fiberoptic bronchoscopy sedation [J]. Journal of Clinical Pediatrics, 2025, 43(1): 50-55.
[4]	JIANG Weiqin, WANG Jing, CHENG Anna, CHEN Tingting, HUANG Yujuan. Predictors of recurrent febrile seizures during the same febrile illness in children with febrile seizures [J]. Journal of Clinical Pediatrics, 2025, 43(1): 8-13.
[5]	QIU Xiu, WEI Dongmei, LIN Shanshan, XIA Huimin, ZHOU Wenhao. Principles and practice of the Born in Guangzhou Cohort Study [J]. Journal of Clinical Pediatrics, 2024, 42(9): 747-752.
[6]	FAN Jianxia. The origins and development of the healthy life trajectory program: a cohort of community-family-mother-child multidimensional interventions for overweight and obesity in children [J]. Journal of Clinical Pediatrics, 2024, 42(9): 768-773.
[7]	JIANG Tao, LI Shuangjie, TANG Lian, OUYANG Wenxian. Immunobiological properties of peripheral blood MAIT cells in children with chronic hepatitis B [J]. Journal of Clinical Pediatrics, 2024, 42(9): 787-790.
[8]	ZHOU Jie, LIU Keqiang, WANG Jinling, WANG Ying. Megacystis-microcolon-intestinal hypoperistalsis syndrome caused by MYH11 elongating mutation : a case report and literatures review [J]. Journal of Clinical Pediatrics, 2024, 42(9): 798-804.
[9]	CHU Sijia, TANG Jihong. Research progress of central nervous system injury associated with pediatric acute lymphoblastic leukemia and its treatment [J]. Journal of Clinical Pediatrics, 2024, 42(9): 811-816.
[10]	DING Yaping, XIA Shanshan, ZHANG Chenmei. Interpretation of “2023 Children’s Renal Nutrition Working Group Clinical Practice Recommendations: Nutritional Management of Children with Acute Kidney Injury” [J]. Journal of Clinical Pediatrics, 2024, 42(8): 667-672.
[11]	LI Yirong, LI Huiping, GAO Jingyu, XIAO Yuhua, CHEN Xiaomin, LU Yanling, ZHAO Nana, FENG Xiaoqin. Comparison of different doses of cytarabine for induction chemotherapy in children with acute myeloid leukemia in FLAG-IDA regimen [J]. Journal of Clinical Pediatrics, 2024, 42(8): 673-677.
[12]	HUANG Bo, DONG Yanying, SONG Linlan. Clinical characteristics of 348 children with infectious mononucleosis [J]. Journal of Clinical Pediatrics, 2024, 42(8): 678-683.
[13]	WANG Dan, SHAO Jingbo, LI Hong, ZHANG Na, ZHU Jiashi, FU Pan, WANG Zhen. Clinical analysis of 38 cases of hematological malignancies complicated with tumor lysis syndrome in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 684-690.
[14]	MA Yan, WEI Xingjiao, BAI Hua, ZHANG Yan, TIAN Xinmin, Aqsa Ahmad, LIANG Lijun. Analysis of etiological composition and clinical features of stage 5 chronic kidney disease in children in a tertiary hospital in western China [J]. Journal of Clinical Pediatrics, 2024, 42(8): 697-703.
[15]	WANG Ye, ZHANG Linlin, CHI Zuofei, SUN Ruowen, JIANG Zehui, XU Gang. A case of clinical report of T-lymphoblastic lymphoma secondary to acute promyelocytic leukemia in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 722-727.